131 related articles for article (PubMed ID: 9490506)
21. Differences in the cytologic characteristics of antibody-dependent cellular cytotoxicity of normal and leukemic bovine blood lymphocytes.
Adomaitiene D; Dediniene J
Anal Quant Cytol; 1981 Jun; 3(2):143-8. PubMed ID: 7258857
[TBL] [Abstract][Full Text] [Related]
22. The use of antibody-coated liposomes as a target cell model for antibody-dependent cell-mediated cytotoxicity.
Geiger B; Schreiber AD
Clin Exp Immunol; 1979 Jan; 35(1):149-54. PubMed ID: 428143
[TBL] [Abstract][Full Text] [Related]
23. Relationship between antibody-dependent cell-mediated cytotoxicity due to anti-HTLV-1 and negative signal of major histocompatibility complex class I antigens on adult T-cell leukemia cell lines.
Komatsu F; Tamiya H
Oncol Res; 1998; 10(2):59-67. PubMed ID: 9666513
[TBL] [Abstract][Full Text] [Related]
24. Antibody penetration into living cells. V. Interference between two fc gamma receptor-mediated functions: antibody penetration and antibody-dependent cellular cytotoxicity.
Llerena JM; Ruíz-Argüelles A; Alarcón-Segovia D; Llorente L; Díaz-Jouanen E
Immunology; 1981 Jun; 43(2):249-54. PubMed ID: 6972908
[TBL] [Abstract][Full Text] [Related]
25. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
[TBL] [Abstract][Full Text] [Related]
26. Quantitative in vivo comparisons of the Fc gamma receptor-dependent agonist activities of different fucosylation variants of an immunoglobulin G antibody.
Scallon B; McCarthy S; Radewonuk J; Cai A; Naso M; Raju TS; Capocasale R
Int Immunopharmacol; 2007 Jun; 7(6):761-72. PubMed ID: 17466910
[TBL] [Abstract][Full Text] [Related]
27. The effect of bryostatin 1 on human lymphocyte-mediated cytotoxicity.
Tilden AB; Kraft AS
J Immunother (1991); 1991 Apr; 10(2):96-104. PubMed ID: 1828367
[TBL] [Abstract][Full Text] [Related]
28. Effect of interferon on antibody-dependent cellular cytotoxicity (ADCC) in chickens.
Mándi Y; Bakay M; Béládi I
Acta Microbiol Hung; 1984; 31(2):127-33. PubMed ID: 6464658
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Fc gamma receptor subtype expression on a human eosinophilic leukemia cell line EoL-3: participation of cAMP and protein kinase C in the effects of interferon-gamma and phorbol ester.
Nambu M; Watanabe H; Kim KM; Tanaka M; Mayumi M; Mikawa H
Cell Immunol; 1991 Mar; 133(1):27-40. PubMed ID: 1846782
[TBL] [Abstract][Full Text] [Related]
30. IgG-mediated enhancement of antibody responses is low in Fc receptor gamma chain-deficient mice and increased in Fc gamma RII-deficient mice.
Wernersson S; Karlsson MC; Dahlström J; Mattsson R; Verbeek JS; Heyman B
J Immunol; 1999 Jul; 163(2):618-22. PubMed ID: 10395649
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-10 down-regulates oxidative metabolism and antibody-dependent cellular cytotoxicity of human neutrophils.
Capsoni F; Minonzio F; Ongari AM; Carbonelli V; Galli A; Zanussi C
Scand J Immunol; 1997 Mar; 45(3):269-75. PubMed ID: 9122616
[TBL] [Abstract][Full Text] [Related]
32. Lymphocyte Fc gamma-receptor blocking antibodies in intravenous gammaglobulin preparations.
Cocker JE; Templeton G; Peel MG; Crawford RJ; Crichton WB; Sandilands GP
J Clin Lab Immunol; 1987 Feb; 22(2):85-90. PubMed ID: 2955119
[TBL] [Abstract][Full Text] [Related]
33. Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells.
Würflein D; Dechant M; Stockmeyer B; Tutt AL; Hu P; Repp R; Kalden JR; van de Winkel JG; Epstein AL; Valerius T; Glennie M; Gramatzki M
Cancer Res; 1998 Jul; 58(14):3051-8. PubMed ID: 9679970
[TBL] [Abstract][Full Text] [Related]
34. Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa.
Iida S; Misaka H; Inoue M; Shibata M; Nakano R; Yamane-Ohnuki N; Wakitani M; Yano K; Shitara K; Satoh M
Clin Cancer Res; 2006 May; 12(9):2879-87. PubMed ID: 16675584
[TBL] [Abstract][Full Text] [Related]
35. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
36. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
[TBL] [Abstract][Full Text] [Related]
37. Synergistic expression of inducible nitric oxide synthase by phorbol ester and interferon-gamma is mediated through NF-kappaB and ERK in microglial cells.
Han IO; Kim HS; Kim HC; Joe EH; Kim WK
J Neurosci Res; 2003 Sep; 73(5):659-69. PubMed ID: 12929133
[TBL] [Abstract][Full Text] [Related]
38. Antagonistic action of IFN-beta and IFN-gamma on high affinity Fc gamma receptor expression in healthy controls and multiple sclerosis patients.
Van Weyenbergh J; Lipinski P; Abadie A; Chabas D; Blank U; Liblau R; Wietzerbin J
J Immunol; 1998 Aug; 161(3):1568-74. PubMed ID: 9686625
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of the gamma interferon receptor in mice].
Cofano F; Fassio A; Cavallo G; Landolfo S
G Batteriol Virol Immunol; 1985; 78(1-6):70-6. PubMed ID: 2943626
[TBL] [Abstract][Full Text] [Related]
40. Fc gamma receptor-mediated activation of phospholipase D regulates macrophage phagocytosis of IgG-opsonized particles.
Kusner DJ; Hall CF; Jackson S
J Immunol; 1999 Feb; 162(4):2266-74. PubMed ID: 9973503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
